news
Biovectra teams up with Revolution Biomanufacturing in mRNA
The companies’ partnership covers messenger RNA design and production services.
List view / Grid view
Contract Development and Manufacturing Organisation (CDMO)
news
PharmaLab previews new conference tracks ahead of 2025 Düsseldorf event
The pharmaceutical laboratory meeting adds sessions on AI in labs, and quality in biologics, mRNA and analytics.
news
CRDMO BioDuro appoints Yaohui Ji as global president for CMC
He joins from contract development and manufacturing organisation Porton Pharma Solutions.
news
Hovione doubles spray drying capacity with $100m US investment round
The CDMO’s New Jersey manufacturing site expansion will eventually cover more than 200,000 square feet.
news
Merck acquires JSR Life Sciences chromatography business
Strengthens its downstream process offering with the addition of JSR’s Amsphere Protein A resin technology.
news
Novo Nordisk manufacturing facility, and clients, hit by FDA action
Regulator classifies former Catalent site as ‘official action indicated’, impacting biotech clients such as Regeneron.
news
Rovi’s injectables CDMO rebrands as Rois and acquires BMS facility
Gains US-based operations with its new Phoenix, Arizona injectable drug product manufacturing and packaging site.
news
CDMO Wheeler Bio appoints Jay Benson as chief operating officer
He joins the US company with over two decades of experience in pharma operations, supply chain and manufacturing.
news
Manufacturing roundup: Symbiosis, BioGrad, Abzena, Eschbach and more
This update includes sterile manufacturing, bio-manufacturing, cell line development and radiopharmaceuticals.
news
Polpharma Biologics splits into biosimilars and CDMO businesses
Contract development and manufacturing services will be provided as Rezon Bio from Poland, with the biosimilars company operating from Switzerland.
news
Bayer breaks ground on German cell and gene therapy centre
Once completed, the Berlin site will also be the new home for one of the company’s Bayer Co. Lab start-up incubators.
news
Boehringer Ingelheim signs gene therapy manufacturing deal with AnGes
The German pharma company’s BioXcellence arm will supply the drug substance for AnGes’ peripheral arterial disease treatment Collategene.
news
WuXi Biologics granted novel authorisation for commercial biologic manufacturing in Ireland
The EMA’s decision permits WuXi Biologics to progress with commercial manufacturing of a global client’s innovative biologic.
news
Bionova Scientific opens pDNA facility in the US
The CDMO’s new site will support its work in cell and gene therapy.
